NO20052568L - Fremgangsmate for fremstilling av makrolidforbindelse - Google Patents

Fremgangsmate for fremstilling av makrolidforbindelse

Info

Publication number
NO20052568L
NO20052568L NO20052568A NO20052568A NO20052568L NO 20052568 L NO20052568 L NO 20052568L NO 20052568 A NO20052568 A NO 20052568A NO 20052568 A NO20052568 A NO 20052568A NO 20052568 L NO20052568 L NO 20052568L
Authority
NO
Norway
Prior art keywords
compound
macrolide compound
streptomyces
represented
formula
Prior art date
Application number
NO20052568A
Other languages
English (en)
Other versions
NO20052568D0 (no
Inventor
Satoshi Yamamoto
Susumu Takeda
Takashi Sakai
Takasi Nakashima
Akifumi Okuda
Katsura Kaneko
Taira Kato
Naota Kawamura
Original Assignee
Mercian Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mercian Corp filed Critical Mercian Corp
Publication of NO20052568D0 publication Critical patent/NO20052568D0/no
Publication of NO20052568L publication Critical patent/NO20052568L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SAMMENDRAG Det tilveiebringes en ny fremgangsmåte for fremstilling av en 12-leddet makrolidforbindelse 11107D som har en antitumoraktivitet via biologisk omdanning. Den 12-leddede makrolidforbindelse 11107B representert ved formel (I), som er en utgangssubstans, inkuberes i nærvær av en stamme som er i stand til å omdanne den til forbindelsen 1110 7D representert ved formel (II) som tilhører slekten Mortierella eller Streptomyces eller familien Micromonosporaceae (f.eks. Streptomyces sp. AB-1704 stamme (FERM BP-8551)) eller et dyrket cellepreparat derav sammen med oksygen og deretter høstes målforbindelsen 11107D fra inkubasjonsmediet.
NO20052568A 2002-11-29 2005-05-27 Fremgangsmate for fremstilling av makrolidforbindelse NO20052568L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002346796 2002-11-29
PCT/JP2003/015170 WO2004050890A1 (ja) 2002-11-29 2003-11-27 マクロライド系化合物の製造方法

Publications (2)

Publication Number Publication Date
NO20052568D0 NO20052568D0 (no) 2005-05-27
NO20052568L true NO20052568L (no) 2005-06-29

Family

ID=32462862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052568A NO20052568L (no) 2002-11-29 2005-05-27 Fremgangsmate for fremstilling av makrolidforbindelse

Country Status (13)

Country Link
US (1) US7745198B2 (no)
EP (1) EP1580278A4 (no)
JP (1) JP4439401B2 (no)
KR (1) KR20050086873A (no)
CN (1) CN1717493A (no)
AU (1) AU2003284469B2 (no)
BR (1) BR0316746A (no)
CA (1) CA2507641A1 (no)
MX (1) MXPA05005672A (no)
NO (1) NO20052568L (no)
NZ (1) NZ540103A (no)
RU (1) RU2330069C2 (no)
WO (1) WO2004050890A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7932083B2 (en) 2003-11-27 2011-04-26 Mercian Corporation DNA participating in hydroxylation of macrolide compound
US8008049B2 (en) * 2004-07-20 2011-08-30 Eisai R&D Management Co., Ltd. DNA coding for polypeptide participating in biosynthesis of pladienolide
TW200716744A (en) * 2005-05-26 2007-05-01 Eisai R&D Man Co Ltd Genetically modified microorganism and process for production of macrolide compound using the microorganism
CN101282967B (zh) 2005-10-13 2011-01-26 卫材R&D管理有限公司 普拉二烯内酯b和普拉二烯内酯d的全合成
AU2007285215A1 (en) * 2006-08-14 2008-02-21 Eisai R & D Management Co., Ltd. Stable lyophilized preparation
NZ575828A (en) * 2007-01-29 2011-04-29 Eisai R&D Man Co Ltd Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
CN111825733A (zh) * 2013-04-04 2020-10-27 哈佛大学的校长及成员们 大环内酯及其制备和使用方法
WO2015175594A1 (en) 2014-05-15 2015-11-19 Eisai R&D Management Co., Ltd. Pladienolide pyridine compounds and methods of use
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
US10640528B2 (en) 2015-03-25 2020-05-05 President And Fellows Of Havard College Macrolides with modified desosamine sugars and uses thereof
EP3344780B1 (en) 2015-09-01 2021-06-23 Eisai R&D Management Co., Ltd. Splice variants associated with neomorphic sf3b1 mutants
US10745387B2 (en) 2015-11-18 2020-08-18 Eisai R&D Management Co., Ltd. Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof
WO2018170129A1 (en) 2017-03-15 2018-09-20 Eisai Co., Ltd Spliceosome mutations and uses thereof
MX2020004179A (es) 2017-10-31 2020-08-03 Eisai R&D Man Co Ltd Combinacion que comprende al menos un modulador de espliceosomas y al menos un inhibidor elegido de inhibidores de bcl2, bcl2/bclxl y bclxl, y metodos de uso.
TW201945351A (zh) 2018-04-09 2019-12-01 日商衛材R&D企管股份有限公司 特定普拉二烯內酯化合物及其使用方法
CN117285502A (zh) 2018-04-12 2023-12-26 卫材R&D管理有限公司 作为用于治疗癌症的剪接体靶向剂的普拉二烯内酯衍生物
KR20210016406A (ko) 2018-06-01 2021-02-15 에자이 알앤드디 매니지먼트 가부시키가이샤 스플라이싱 조정제를 사용하는 방법
KR20230104204A (ko) 2020-11-04 2023-07-07 에자이 알앤드디 매니지먼트 가부시키가이샤 골수이형성 증후군(mds)에 대한 바이오마커 및 이를 사용하는 방법
CN114478257A (zh) * 2021-12-29 2022-05-13 福建省山河药业有限公司 一种抗肿瘤霉菌酸类化合物及其制备方法、应用
WO2023131866A1 (en) 2022-01-05 2023-07-13 Eisai R&D Management Co., Ltd. Biomarkers for myelodysplastic syndrome (mds) and methods of using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04352783A (ja) * 1991-05-27 1992-12-07 Taisho Pharmaceut Co Ltd １２員環マクロライド系化合物
AU5179800A (en) 1999-06-03 2000-12-28 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Mycolactone and related compounds, compositions and methods of use
AU2001278155A1 (en) 2000-08-03 2002-02-18 Kosan Biosciences, Inc. Fermentation and purification of mycolactones
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI233361B (en) 2001-04-13 2005-06-01 Gen Hospital Corp Methods of preventing UVB-induced skin damage
TWI334866B (en) 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7256178B2 (en) * 2002-07-31 2007-08-14 Eisai Co., Ltd. Physiologically active substances
CN101282967B (zh) 2005-10-13 2011-01-26 卫材R&D管理有限公司 普拉二烯内酯b和普拉二烯内酯d的全合成

Also Published As

Publication number Publication date
NZ540103A (en) 2007-05-31
AU2003284469B2 (en) 2008-02-21
JP4439401B2 (ja) 2010-03-24
EP1580278A4 (en) 2010-08-25
AU2003284469A1 (en) 2004-06-23
US20060141589A1 (en) 2006-06-29
EP1580278A1 (en) 2005-09-28
BR0316746A (pt) 2005-10-18
CA2507641A1 (en) 2004-06-17
NO20052568D0 (no) 2005-05-27
RU2005120390A (ru) 2006-01-27
WO2004050890A1 (ja) 2004-06-17
JPWO2004050890A1 (ja) 2006-03-30
MXPA05005672A (es) 2005-08-16
RU2330069C2 (ru) 2008-07-27
KR20050086873A (ko) 2005-08-30
CN1717493A (zh) 2006-01-04
US7745198B2 (en) 2010-06-29

Similar Documents

Publication Publication Date Title
NO20052568L (no) Fremgangsmate for fremstilling av makrolidforbindelse
Zheng et al. E ndomicrobium proavitum, the first isolate of E ndomicrobia class. nov.(phylum E lusimicrobia)–an ultramicrobacterium with an unusual cell cycle that fixes nitrogen with a G roup IV nitrogenase
Hur et al. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein
Riedlinger et al. Auxofuran, a novel metabolite that stimulates the growth of fly agaric, is produced by the mycorrhiza helper bacterium Streptomyces strain AcH 505
KR101021234B1 (ko) 미생물에 의한 비타민 ｃ의 생성 방법
Ladapo et al. Method for isolation of auxotrophs in the methanogenic archaebacteria: role of the acetyl-CoA pathway of autotrophic CO2 fixation in Methanococcus maripaludis.
Chen et al. Epigenetic modifier-induced biosynthesis of novel fusaric acid derivatives in endophytic fungi from Datura stramonium L.
DK149080B (da) Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
NO991863L (no) Nye bakteriestammer og bruken derav i fermenteringsprosesser for 2-keto-L-gulonsyreproduksjon
BRPI0208535B8 (pt) método para a produção de lipopolissacarídeo que pode gerar 3-o-4’-monofosforil desacilado lipídeo a
NO20075911L (no) Genetisk modifisert mikroorganisme og fremgangsmate for fremstilling av makrolidforbindelser ved anvendelse av mikroorganismen
DK1711593T3 (da) Fremgangsm de til fremstilling af L-aminosyrer ved anvendelse af stammer fra familien Enterobacteriaceae
NO20070802L (no) Gener som koder for forgrent-kjede alfa-ketosyre-dehydrogenase-kompleks fra Streptomyces avermitilis.
Limtong et al. Effect of acetic acid on growth and ethanol fermentation of xylose fermenting yeast and Saccharomyces cerevisiae
Hakalehto et al. Dualistic acidic and neutral glucose fermentation balance in small intestine: Simulation in vitro
US2917435A (en) Preparation of 2-keto-1-gulonic acid by pseudomonas aeruginosa
Kizuka et al. Studies on actinomycetes isolated from plant leaves
MX2007008155A (es) Metodo para producir compuestos derivados probioticamente.
Petrescu et al. A yeast strain that uses D-galacturonic acid as a substrate for L-ascorbic acid biosynthesis
NO944197L (no) Moenomycin-avspaltningsprodukter med hydroksylert og oksydert lipidsidekjede
HU196627B (en) Microbiological process for producing y alpha-hydroxy-4-androstene-3,17-dione
Che et al. Barbaloin stimulates growth of Eubacterium sp. strain BAR, a barbaloin-metabolizing bacterium from human feces
Mandal et al. Induction of nodD gene in a Betarhizobium isolate, Cupriavidus sp. of Mimosa pudica, by root nodule phenolic acids
Hasegawa Studies on motile arthrospore-bearing rare actinomycetes
Lampen Metabolism of nucleic acid components in bacteria

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application